1. Home
  2. NTRA vs PAYX Comparison

NTRA vs PAYX Comparison

Compare NTRA & PAYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$212.07

Market Cap

29.1B

Sector

Health Care

ML Signal

HOLD

Logo Paychex Inc.

PAYX

Paychex Inc.

HOLD

Current Price

$100.63

Market Cap

34.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
PAYX
Founded
2003
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
29.1B
34.8B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
NTRA
PAYX
Price
$212.07
$100.63
Analyst Decision
Strong Buy
Hold
Analyst Count
15
16
Target Price
$259.07
$111.67
AVG Volume (30 Days)
1.3M
2.7M
Earning Date
05-07-2026
03-25-2026
Dividend Yield
N/A
4.59%
EPS Growth
0.65
N/A
EPS
N/A
3.71
Revenue
$210,939,000.00
$5,571,700,000.00
Revenue This Year
$18.08
$19.19
Revenue Next Year
$19.65
$5.50
P/E Ratio
N/A
$26.78
Revenue Growth
N/A
5.56
52 Week Low
$131.81
$85.45
52 Week High
$256.36
$154.90

Technical Indicators

Market Signals
Indicator
NTRA
PAYX
Relative Strength Index (RSI) 51.37 58.30
Support Level $186.96 $87.59
Resistance Level $222.53 $101.96
Average True Range (ATR) 10.51 2.71
MACD 0.34 0.14
Stochastic Oscillator 51.46 73.30

Price Performance

Historical Comparison
NTRA
PAYX

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About PAYX Paychex Inc.

Paychex is a cloud-based human capital management provider offering payroll, compliance, talent management, benefits administration, and retirement services. The firm also provides HR outsourcing services, including professional employer organization, or PEO, offerings, enabling clients to reduce HR overhead. Paychex primarily targets small and midsize businesses, although its acquisition of Paycor in 2025 signals the firm's aspirations to expand into the midmarket segment, serving firms with more than 100 employees. As of fiscal 2025, Paychex has approximately 800,000 clients and manages payroll for one in 11 workers in the United States.

Share on Social Networks: